This inventor holds 12 USPTO granted patents and 3 published patent applications. Top assignees: U.S. Nutraceuticals, LLC, Tonix Pharma Limited, University of Alberta. Active years: 1987-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toronto, CA (1987 - 1995)
- Edmonton, CA (2011 - 2022)
Company Filing History:
5 out of 57 
2 out of 4 
2 out of 455 
Years Active: 1987-2026
Title: The Innovative Contributions of Inventor David Evans
Introduction
David Evans, an accomplished inventor based in Edmonton, Canada, has made significant strides in the field of biotechnology. With a commendable portfolio of 10 patents, Evans is poised as a notable figure in the development of synthetic chimeric poxviruses and oncolytic virotherapy.
Latest Patents
His latest patents have established him as a pioneer in the field of synthetic biological agents. One of his key inventions, "Synthetic Chimeric Poxviruses," relates to the creation of synthetic chimeric poxviruses and compositions involving these viruses. This invention highlights systems and methods for producing such poxviruses that are ideal for live virus vaccines and pharmaceutical formulations.
In another groundbreaking patent, "Oncolytic Viruses and Methods for Treating Neoplastic Disorders," Evans provides mutant ribonucleotide reductase strains of poxviruses, including vaccinia viruses. This patent underscores innovative methods for utilizing these mutant strains in oncolytic virotherapy, offering novel approaches to treat various neoplastic conditions. Furthermore, the disclosure includes vector constructs for generating these strains, which could have transformative implications in cancer treatment.
Career Highlights
Throughout his career, David Evans has garnered invaluable experience, prominently contributing to the biotechnology sector. He has worked with U.S. Nutraceuticals, LLC, among other companies, where he applied his expertise in developing pioneering biotechnological solutions.
Collaborations
Collaboration has been a cornerstone of Evans' work. He has partnered with notable colleagues, including W. Stephen Hill and Don B. Gammon, leveraging their combined expertise to drive innovations that address critical health challenges.
Conclusion
David Evans stands out as a trailblazer in biotechnology, illustrating the profound impact of his inventions on the treatment of diseases through innovative methods and applications. His patents not only advance scientific understanding but also pave the way for future research and medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile